Canada markets closed

EMVision Medical Devices Ltd (EMV.AX)

ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
2.1500-0.0500 (-2.27%)
At close: 04:10PM AEST
Currency in AUD

Valuation Measures4

Market Cap (intraday) 167.61M
Enterprise Value 162.10M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)32.16
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -70.72

Trading Information

Stock Price History

Beta (5Y Monthly) 1.58
52-Week Change 331.90%
S&P500 52-Week Change 322.36%
52 Week High 32.7200
52 Week Low 31.1300
50-Day Moving Average 32.3790
200-Day Moving Average 31.8238

Share Statistics

Avg Vol (3 month) 363.59k
Avg Vol (10 day) 370.35k
Shares Outstanding 585.42M
Implied Shares Outstanding 685.42M
Float 848.91M
% Held by Insiders 139.54%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -37.17%
Operating Margin (ttm)4.75%

Management Effectiveness

Return on Assets (ttm)-16.10%
Return on Equity (ttm)-47.66%

Income Statement

Revenue (ttm)8.68M
Revenue Per Share (ttm)0.12
Quarterly Revenue Growth (yoy)34.40%
Gross Profit (ttm)N/A
EBITDA -2.69M
Net Income Avi to Common (ttm)-3.22M
Diluted EPS (ttm)-0.0400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.48M
Total Cash Per Share (mrq)0.11
Total Debt (mrq)2.97M
Total Debt/Equity (mrq)52.07%
Current Ratio (mrq)1.91
Book Value Per Share (mrq)0.07

Cash Flow Statement

Operating Cash Flow (ttm)-3.41M
Levered Free Cash Flow (ttm)-2.06M